BIOC
Biocept, Inc.
BIOC
BIOC
Delisted
BIOC was delisted on the 24th of October, 2023.
26 hedge funds and large institutions have $8.12M invested in Biocept, Inc. in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
26
Holding in Top 10
–
Calls
$649K
Puts
$290K
Top Buyers
| 1 | +$1.29M | |
| 2 | +$831K | |
| 3 | +$421K | |
| 4 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
+$208K |
| 5 |
Renaissance Technologies
New York
|
+$204K |
Top Sellers
| 1 | -$666K | |
| 2 | -$322K | |
| 3 | -$302K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$236K |
| 5 |
VF
Virtu Financial
New York
|
-$80K |